-
Hoʻokahi ʻano hana hoʻohui kemika o ka hana ʻana (S)-4-N-Boc-2-methylpiperazine CAS: 147081-29-6
Inoa: (S)-4-N-Boc-2-methylpiperazine CAS: 147081-29-6 Noi: ʻO ia kekahi o nā mea kūlohelohe, e like me AMG-510 Hiki ke loaʻa iā ia ma ka hopena hoʻokahi o ka S-2-Methylpiperazion Detail o ka hoʻomākaukau: E hoʻohui i ka wai (500g, 5w/w%) i loko o ka ʻōmole hopena.Hoʻohui (s) -2-methylpiperazine (100g, 998.4mmol, 1...Heluhelu hou aku -
Loaʻa ʻo Lilly i ka ʻae FDA no Mounjaro e mālama i ka maʻi diabetes type 2 i nā pākeke
Na NS Healthcare Staff Writer 16 Mei 2022 E hāʻawi ʻia ʻo Mounjaro i ʻeono mau kau, 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg, a me 15mg, me ka peni injector auto-injector a Lilly e hele mai me kahi nila i hoʻopili mua ʻia ʻo Mounjaro. ʻO ia ka GIP a me GLP-1 receptor agonist.(Ke kālā: Lilly USA, LLC.) ʻO Eli Lilly a me ...Heluhelu hou aku -
Hiki ke lanakila ʻia ka pahuhopu paʻakikī loa!Aia ʻo Adagrassib, kahi lāʻau lapaʻau hou no ka maʻi kanesa maʻi, aia ma ka mākeke!
Ma Pepeluali 15, 2022, ua ʻae ka US Food and Drug Administration (FDA) i ka adagrassib new drug application (NDA) no ka mālama ʻana i nā poʻe maʻi me ka maʻi maʻi ʻaʻai liʻiliʻi liʻiliʻi liʻiliʻi (NSCLC) me KRAS G12C mutation i loaʻa ma ka liʻiliʻi hoʻokahi systemic. lapaʻau ma mua.Ma lalo o ka lāʻau lapaʻau u ...Heluhelu hou aku -
ʻO Porton: ʻO ka loaʻa kālā o CDMO o ka gene cell therapy he 13.87 miliona yuan, piʻi 897% makahiki ma ka makahiki
Ma Malaki 25, ua hoʻokuʻu ʻo Porton Shares (300363) i kāna hōʻike makahiki: I ka makahiki 2021, ua loaʻa ka ʻoihana i ka loaʻa kālā o 3.105 biliona yuan, ʻoi aku ka 50% makahiki ma ka makahiki, a ua hōʻea ka nui o ka loaʻa kālā.ʻO ka loaʻa kālā i hāʻawi ʻia i nā mea kuleana o nā ʻoihana i helu ʻia ma hope o ka haʻalele ʻana i ka g...Heluhelu hou aku -
Ua kau inoa ʻo Apeloa Pharmaceutical i kahi ʻaelike me MPP e hana i ka lāʻau lapaʻau COVID-19 waha a Pfizer i 95 mau ʻāina haʻahaʻa a waena.
Ma ka lā 19 o Malaki, ʻo Apeloa Pharmaceutical Co., LTD.(ka helu helu: 000739) i hoʻolaha ʻia, Ua hoʻopaʻa inoa ka Hui i ka ʻaelike Laikini me MPP (ka "Drug Patent Pool Organization"), hāʻawi ʻo MPP i ka ʻoihana no ka nematvir. .Heluhelu hou aku -
ʻO Sanofi a me SOBI: ʻO ka recombinant factor VIII therapy hiki i kahi pae III hope no ka hemophilia A nui.
Ma Malaki 9,2022, ua hoʻopuka ʻo Sanofi a me kāna hoa hana Swedish Orphan Biovitrum AB ("SOBI"), kahi hui biopharmaceutical honua e pili ana i nā maʻi laha, ua hoʻokuʻu i nā hopena maikaʻi no kā lākou hoʻāʻo ʻana i ka pae III, XTEND-1, no ka hemophilia A moho Efanesoctocog alfa ( BIVV001). ʻAʻole kēia...Heluhelu hou aku -
ʻO ka hōʻuluʻulu o ka ʻae ʻana i ka lāʻau hou a me nā hōʻailona hoʻonui ʻia no ka FDA ma Ianuali 2022
1.Quviviq Quviviq (inoa maʻamau: daridorexant) he lāʻau lapaʻau ia no ka insomnia a he ʻelua orexin receptor antagonist (OXR). Hoʻokō ʻia ke ʻano hana lapaʻau ma ka hoʻokūkū hoʻokūkū o OXR1 a me OXR2, ke kāohi ʻana i ka hana hōʻailona orexin a no laila ke kāohi nei i ke ala ala e pale ai. ka hypera...Heluhelu hou aku -
ʻO ka wānana TOP10 hou no kahi mea kūʻai maikaʻi loa ma 2022
I kēia mau lā, ua paʻi ʻia e ka Nature subsidiary magazine Nature Review Drug Discovery a me ka media biomedical industry Evaluate Vantage i nā ʻatikala e pili ana i ka nānā ʻana a me ka wānana o ke kūʻai ʻana o ka lāʻau lapaʻau honua o Top10 ma 2022. ʻelua ...Heluhelu hou aku -
Me ka helu ʻana o nā kūʻai lāʻau lapaʻau sclerosis lehulehu i hoʻokuʻu ʻia ma 2021, ua paʻa ka Roche Ocrevus i ka mua.
Me ka hoʻokuʻu ʻana o nā hopena kālā o nā ʻoihana i ka makahiki 2021, ua hoʻokuʻu ʻia ka papa inoa kūʻai o nā lāʻau lapaʻau sclerosis (MS) ma 2021, e like me ka papa inoa ma lalo nei. ʻoi aku ma mua o $ 1 biliona.ʻO Roche ...Heluhelu hou aku -
2022 Hoʻolaha hoʻomaha hoʻomaha hoʻolauleʻa puna
E ka mea kūʻai aku: Ke hele mai nei ka Spring Festival o 2022.Hoʻohui ʻia me ke kūlana mālama pono o ka hale hana hana o kā mākou hui, ua hoʻoholo ka hui e hoʻolaha ʻia ka lā hoʻomaha Spring Festival 2022 penei: I. Production Department mai Ianuali 19, 2022 a Februar...Heluhelu hou aku -
Ua komo ka paipu lāʻau hoʻolālā kōkua AI i ka pae IND-Enabling Studies i loko o 8 mahina
Ma Ianuali 17,2022, e kālele ana i ka hoʻohana ʻana i ka hoʻomohala ʻana i ka lāʻau lapaʻau i hoʻokumu ʻia e ka naʻauao, e hoʻohana i kāna noiʻi kūʻokoʻa a me ka hoʻomohala ʻana o ka hui ʻana o AI hou ʻike lāʻau lapaʻau Molecule Pro, i loko o 8 mau mahina e hoʻolālā, hōʻoia ʻia 69 mau mole liʻiliʻi hou a loaʻa no kahi papa. BG pūmua...Heluhelu hou aku -
ʻO ka noiʻi hou loa: ʻaʻole hiki ke pale i ka lāʻau lapaʻau piha iā Oikjon, ʻo ka hoʻoikaika ʻana i ka pono o ka nila he 37% wale nō.
Ma mua o ka loaʻa ʻana o ka poʻe he nui i ke kolu o ka pana ʻana, hiki mai kahi ʻōlelo aʻo hou mai ka Luna Nui o Moderna. I kēia mau lā, ua ʻōlelo ʻo ia i ka lehulehu e like me ka emi ʻana o ka lāʻau lapaʻau i ka manawa, pono paha nā kānaka i ka hā o ka hāʻule e hoʻoikaika i ka pale.Ua ʻōlelo ʻo Stephane Bancel i ka poʻe e loaʻa ana i nā nila booster i ka hāʻule hope ma ...Heluhelu hou aku
Welcom iā Sichuan Hengkang Science and Technology Development Co., Ltd.
